Effect of add-on therapy with Traditional Chinese Medicine on the survival of patients with anemic lower-risk myelodysplastic syndromes in the real-world setting: a retrospective study.

• Tác giả: Zhao Lin, Q U Weiying, Tan Xyucheng, Y U Yanan, Zhao Yihan
• Ngôn ngữ: eng
• Thông tin xuất bản: China : Journal of traditional Chinese medicine = Chung i tsa chih ying wen pan , 2025
• Bộ sưu tập: NCBI
• ID: 197854

Tóm tắt

OBJECTIVE: To illustrate the effect of add-on therapy of Traditional Chinese Medicine (TCM) on the long-term survival of anemic lower-risk myelodysplastic syndromes (LR-MDS) patients. METHODS: In this study, we conducted a retrospective analysis of the data of patients with LR-MDS who were identified from Shuguang Hospital between January 2006 and June 2020. The Kaplan-Meier method was used to calculate overall survival (OS), while the Cox model was employed to analyze prognostic factors of long-term survival. A total of 162 patients who met the inclusion criteria were divided into two groups: the TCM group ( RESULTS: There were no significant differences in baseline characteristics. The cumulative survival rate of the TCM group was significantly higher than that of the non-TCM group [log-rank CONCLUSIONS: The integration of TCM and Western Medicine has the potential to extend the OS of LR-MDS patients when compared to the use of Western Medicine alone.